Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

The molecular origin and taxonomy of mucinous ovarian carcinoma.

Cheasley D, Wakefield MJ, Ryland GL, Allan PE, Alsop K, Amarasinghe KC, Ananda S, Anglesio MS, Au-Yeung G, Böhm M, Bowtell DDL, Brand A, Chenevix-Trench G, Christie M, Chiew YE, Churchman M, DeFazio A, Demeo R, Dudley R, Fairweather N, Fedele CG, Fereday S, Fox SB, Gilks CB, Gourley C, Hacker NF, Hadley AM, Hendley J, Ho GY, Hughes S, Hunstman DG, Hunter SM, Jobling TW, Kalli KR, Kaufmann SH, Kennedy CJ, Köbel M, Le Page C, Li J, Lupat R, McNally OM, McAlpine JN, Mes-Masson AM, Mileshkin L, Provencher DM, Pyman J, Rahimi K, Rowley SM, Salazar C, Samimi G, Saunders H, Semple T, Sharma R, Sharpe AJ, Stephens AN, Thio N, Torres MC, Traficante N, Xing Z, Zethoven M, Antill YC, Scott CL, Campbell IG, Gorringe KL.

Nat Commun. 2019 Sep 2;10(1):3935. doi: 10.1038/s41467-019-11862-x.

2.

PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.

Tang M, O'Connell RL, Amant F, Beale P, McNally O, Sjoquist KM, Grant P, Davis A, Sykes P, Mileshkin L, Moujaber T, Kennedy CJ, deFazio A, Tan K, Antill Y, Goh J, Bonaventura T, Scurry J, Friedlander M.

Gynecol Oncol. 2019 Sep;154(3):531-538. doi: 10.1016/j.ygyno.2019.06.011. Epub 2019 Jun 18.

PMID:
31227223
3.

Surgically Managed Ovarian Masses at the Royal Children's Hospital, Melbourne -19 Year Experience.

How JA, Marino JL, Grover SR, Heloury Y, Sullivan M, Mellor A, McNally O, Jayasinghe Y.

J Pediatr Surg. 2019 Sep;54(9):1913-1920. doi: 10.1016/j.jpedsurg.2019.05.005. Epub 2019 May 16.

PMID:
31160084
4.

Pathological process has a crucial role in sentinel node biopsy for vulvar cancer.

Sykes P, Eva L, van der Griend R, McNally O, Blomfield P, Brand A, Tristram A, Bergzoll C, Petrich S, Kenwright D, Payne K, Kellow M, Innes C, Harker D, Perrin L, Cohen P, Jaaback K, Simcock B.

Gynecol Oncol. 2019 May;153(2):292-296. doi: 10.1016/j.ygyno.2019.02.012. Epub 2019 Feb 24.

PMID:
30814024
5.

The diagnostic accuracy of OCT angiography in naive and treated neovascular age-related macular degeneration: a review.

Perrott-Reynolds R, Cann R, Cronbach N, Neo YN, Ho V, McNally O, Madi HA, Cochran C, Chakravarthy U.

Eye (Lond). 2019 Feb;33(2):274-282. doi: 10.1038/s41433-018-0229-6. Epub 2018 Oct 31. Review.

PMID:
30382236
6.

Role of imaging in the routine management of endometrial cancer.

Lin MY, Dobrotwir A, McNally O, Abu-Rustum NR, Narayan K.

Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:109-117. doi: 10.1002/ijgo.12618.

7.

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma.

Kondrashova O, Topp M, Nesic K, Lieschke E, Ho GY, Harrell MI, Zapparoli GV, Hadley A, Holian R, Boehm E, Heong V, Sanij E, Pearson RB, Krais JJ, Johnson N, McNally O, Ananda S, Alsop K, Hutt KJ, Kaufmann SH, Lin KK, Harding TC, Traficante N; Australian Ovarian Cancer Study (AOCS), deFazio A, McNeish IA, Bowtell DD, Swisher EM, Dobrovic A, Wakefield MJ, Scott CL.

Nat Commun. 2018 Sep 28;9(1):3970. doi: 10.1038/s41467-018-05564-z.

8.

'Lest we forget' as we move forward with cervical screening.

Saville M, McNally O.

Aust N Z J Obstet Gynaecol. 2018 Jun;58(3):265-266. doi: 10.1111/ajo.12813. No abstract available.

PMID:
29864221
9.

Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.

Kampan NC, Madondo MT, McNally OM, Stephens AN, Quinn MA, Plebanski M.

Front Immunol. 2017 Nov 6;8:1482. doi: 10.3389/fimmu.2017.01482. eCollection 2017.

10.

Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.

Garsed DW, Alsop K, Fereday S, Emmanuel C, Kennedy CJ, Etemadmoghadam D, Gao B, Gebski V, Garès V, Christie EL, Wouters MCA, Milne K, George J, Patch AM, Li J, Arnau GM, Semple T, Gadipally SR, Chiew YE, Hendley J, Mikeska T, Zapparoli GV, Amarasinghe K, Grimmond SM, Pearson JV, Waddell N, Hung J, Stewart CJR, Sharma R, Allan PE, Rambau PF, McNally O, Mileshkin L, Hamilton A, Ananda S, Grossi M, Cohen PA, Leung YC, Rome RM, Beale P, Blomfield P, Friedlander M, Brand A, Dobrovic A, Köbel M, Harnett P, Nelson BH, Bowtell DDL, deFazio A; Nadia Traficante, for the Australian Ovarian Cancer Study Group.

Clin Cancer Res. 2018 Feb 1;24(3):569-580. doi: 10.1158/1078-0432.CCR-17-1621. Epub 2017 Oct 23.

11.

Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot study.

Cohen PA, Brand A, Sykes P, Wrede DCH, McNally O, Eva L, Rao A, Campion M, Stockler M, Powell A, Codde J, Bulsara MK, Anderson L, Leung Y, Farrell L, Stoyles P.

BMJ Open. 2017 Aug 28;7(8):e017576. doi: 10.1136/bmjopen-2017-017576.

12.

Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities.

Kampan NC, Xiang SD, McNally OM, Stephens AN, Quinn MA, Plebanski M.

Curr Med Chem. 2018;25(36):4785-4806. doi: 10.2174/0929867324666170712160621. Review.

PMID:
28707587
13.

A better model of care after surgery for early endometrial cancer - Comprehensive needs assessment and clinical handover to a woman's general practitioner.

Rio IM, McNally O.

Aust N Z J Obstet Gynaecol. 2017 Oct;57(5):558-563. doi: 10.1111/ajo.12652. Epub 2017 Jul 10.

PMID:
28691771
14.

Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor-Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer.

Bonaventura A, OʼConnell RL, Mapagu C, Beale PJ, McNally OM, Mileshkin LR, Grant PT, Hadley AM, Goh JCH, Sjoquist KM, Martyn J, DeFazio A, Scurry J, Friedlander ML; Paragon Investigators.

Int J Gynecol Cancer. 2017 Jun;27(5):900-906. doi: 10.1097/IGC.0000000000000978.

PMID:
28498256
15.

Metastatic testicular cancer, a Horner's syndrome and brachial plexopathy.

Reid G, Purcell B, McNally O.

QJM. 2017 Sep 1;110(9):585-586. doi: 10.1093/qjmed/hcx092. No abstract available.

PMID:
28472531
16.

Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomy.

Ayres C, Ratnayake G, McNally O, Quinn M.

Int J Gynecol Cancer. 2017 May;27(4):703-707. doi: 10.1097/IGC.0000000000000954.

PMID:
28399030
17.

Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.

Kentwell M, Dow E, Antill Y, Wrede CD, McNally O, Higgs E, Hamilton A, Ananda S, Lindeman GJ, Scott CL.

Gynecol Oncol. 2017 Apr;145(1):130-136. doi: 10.1016/j.ygyno.2017.01.030. Epub 2017 Feb 3.

PMID:
28162234
18.

A community-based model of rapid autopsy in end-stage cancer patients.

Alsop K, Thorne H, Sandhu S, Hamilton A, Mintoff C, Christie E, Spruyt O, Williams S, McNally O, Mileshkin L, Ananda S, Hallo J, Loi S, Scott C, Savas P, Devereux L, O'Brien P, Gunawardena S, Hampson C, Strachan K, Jaravaza RD, Francis V, Young G, Ranson D, Samaranayake R, Stevens D, Boyle S, Fedele C, Topp M, Ho G, Teo ZL, Taylor RA, Papargiris MM, Lawrence MG, Wang H, Risbridger GP, Haynes NM, Medon M, Johnstone RW, Vidacs E, Arnau GM, Vergara IA, Papenfuss AT, McArthur G, Waring P, Carvosso S, Angel C, Gyorki D, Solomon B, Mitchell G, Shanley S, Francis PA, Dawson SJ, Haffenden A, Tidball E, Volchek M, Pyman J, Madadin M, Leditschke J, Cordner S; Melbourne Melanoma Project; Australian Ovarian Cancer Study Group (AOCS); Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Shackleton M, Bowtell DD.

Nat Biotechnol. 2016 Oct;34(10):1010-1014. doi: 10.1038/nbt.3674. Epub 2016 Sep 12. No abstract available.

PMID:
27617737
19.

Ovarian clear cell carcinoma recurrence presenting as subcutaneous nodules.

Wade J, Armon S, McNally OM.

Eur J Gynaecol Oncol. 2016 Aug;37(4):575-577.

PMID:
29894089
20.

Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.

Black C, Feng A, Bittinger S, Quinn M, Neesham D, McNally O.

Int J Gynecol Cancer. 2016 Jan;26(1):133-40. doi: 10.1097/IGC.0000000000000569.

PMID:
26588230
21.

Corrigendum: Whole-genome characterization of chemoresistant ovarian cancer.

Patch AM, Christie EL, Etemadmoghadam D, Garsed DW, George J, Fereday S, Nones K, Cowin P, Alsop K, Bailey PJ, Kassahn KS, Newell F, Quinn MC, Kazakoff S, Quek K, Wilhelm-Benartzi C, Curry E, Leong HS; Australian Ovarian Cancer Study Group, Hamilton A, Mileshkin L, Au-Yeung G, Kennedy C, Hung J, Chiew YE, Harnett P, Friedlander M, Quinn M, Pyman J, Cordner S, O'Brien P, Leditschke J, Young G, Strachan K, Waring P, Azar W, Mitchell C, Traficante N, Hendley J, Thorne H, Shackleton M, Miller DK, Arnau GM, Tothill RW, Holloway TP, Semple T, Harliwong I, Nourse C, Nourbakhsh E, Manning S, Idrisoglu S, Bruxner TJ, Christ AN, Poudel B, Holmes O, Anderson M, Leonard C, Lonie A, Hall N, Wood S, Taylor DF, Xu Q, Fink JL, Waddell N, Drapkin R, Stronach E, Gabra H, Brown R, Jewell A, Nagaraj SH, Markham E, Wilson PJ, Ellul J, McNally O, Doyle MA, Vedururu R, Stewart C, Lengyel E, Pearson JV, Waddell N, deFazio A, Grimmond SM, Bowtell DD.

Nature. 2015 Nov 19;527(7578):398. doi: 10.1038/nature15716. Epub 2015 Oct 21. No abstract available.

PMID:
26503049
22.

Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer.

Kampan NC, Madondo MT, McNally OM, Quinn M, Plebanski M.

Biomed Res Int. 2015;2015:413076. doi: 10.1155/2015/413076. Epub 2015 Jun 7. Review.

23.

Whole-genome characterization of chemoresistant ovarian cancer.

Patch AM, Christie EL, Etemadmoghadam D, Garsed DW, George J, Fereday S, Nones K, Cowin P, Alsop K, Bailey PJ, Kassahn KS, Newell F, Quinn MC, Kazakoff S, Quek K, Wilhelm-Benartzi C, Curry E, Leong HS; Australian Ovarian Cancer Study Group, Hamilton A, Mileshkin L, Au-Yeung G, Kennedy C, Hung J, Chiew YE, Harnett P, Friedlander M, Quinn M, Pyman J, Cordner S, O'Brien P, Leditschke J, Young G, Strachan K, Waring P, Azar W, Mitchell C, Traficante N, Hendley J, Thorne H, Shackleton M, Miller DK, Arnau GM, Tothill RW, Holloway TP, Semple T, Harliwong I, Nourse C, Nourbakhsh E, Manning S, Idrisoglu S, Bruxner TJ, Christ AN, Poudel B, Holmes O, Anderson M, Leonard C, Lonie A, Hall N, Wood S, Taylor DF, Xu Q, Fink JL, Waddell N, Drapkin R, Stronach E, Gabra H, Brown R, Jewell A, Nagaraj SH, Markham E, Wilson PJ, Ellul J, McNally O, Doyle MA, Vedururu R, Stewart C, Lengyel E, Pearson JV, Waddell N, deFazio A, Grimmond SM, Bowtell DD.

Nature. 2015 May 28;521(7553):489-94. doi: 10.1038/nature14410. Erratum in: Nature. 2015 Nov 19;527(7578):398.

PMID:
26017449
24.

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.

Abubaker K, Luwor RB, Zhu H, McNally O, Quinn MA, Burns CJ, Thompson EW, Findlay JK, Ahmed N.

BMC Cancer. 2014 May 6;14:317. doi: 10.1186/1471-2407-14-317.

25.

Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden.

Abubaker K, Luwor RB, Escalona R, McNally O, Quinn MA, Thompson EW, Findlay JK, Ahmed N.

Front Oncol. 2014 Apr 9;4:75. doi: 10.3389/fonc.2014.00075. eCollection 2014.

26.

Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.

van Cromvoirt SM, Thomas CM, Quinn MA, McNally OM, Bekkers RL.

Gynecol Oncol. 2014 Jun;133(3):542-5. doi: 10.1016/j.ygyno.2014.03.018. Epub 2014 Mar 14.

PMID:
24631700
27.

Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts.

Topp MD, Hartley L, Cook M, Heong V, Boehm E, McShane L, Pyman J, McNally O, Ananda S, Harrell M, Etemadmoghadam D, Galletta L, Alsop K, Mitchell G, Fox SB, Kerr JB, Hutt KJ, Kaufmann SH, Australian Ovarian Cancer Study, Swisher EM, Bowtell DD, Wakefield MJ, Scott CL.

Mol Oncol. 2014 May;8(3):656-68. doi: 10.1016/j.molonc.2014.01.008. Epub 2014 Jan 24.

28.

Complex atypical hyperplasia of the endometrium: differences in outcome following conservative management of pre- and postmenopausal women.

Brownfoot FC, Hickey M, Ang WC, Arora V, McNally O.

Reprod Sci. 2014 Oct;21(10):1244-8. doi: 10.1177/1933719114522517. Epub 2014 Feb 10.

PMID:
24516039
29.

Intravenous leiomyomatosis with intracardiac extension - a review of diagnosis and management with an illustrative case.

Clay TD, Dimitriou J, McNally OM, Russell PA, Newcomb AE, Wilson AM.

Surg Oncol. 2013 Sep;22(3):e44-52. doi: 10.1016/j.suronc.2013.03.004. Epub 2013 Apr 30. Review.

PMID:
23642379
30.

LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.

Cowin PA, George J, Fereday S, Loehrer E, Van Loo P, Cullinane C, Etemadmoghadam D, Ftouni S, Galletta L, Anglesio MS, Hendley J, Bowes L, Sheppard KE, Christie EL, Pearson RB, Harnett PR, Heinzelmann-Schwarz V, Friedlander M, McNally O, Quinn M, Campbell P, deFazio A, Bowtell DD; Australian Ovarian Cancer Study.

Cancer Res. 2012 Aug 15;72(16):4060-73.

31.

Routine hysterectomy in the surgical management of ovarian cancer: a retrospective case series, physician opinion survey, and review of the literature.

Bunting MW, Jaaback KS, McNally OM.

Int J Gynecol Cancer. 2011 Dec;21(9):1579-84. doi: 10.1097/IGC.0b013e318227c9ac. Review.

PMID:
21892095
32.

Long-term psychological morbidity, sexual functioning, and relationship outcomes in women with gestational trophoblastic disease.

Stafford L, McNally OM, Gibson P, Judd F.

Int J Gynecol Cancer. 2011 Oct;21(7):1256-63. doi: 10.1097/IGC.0b013e3182259c04.

PMID:
21811174
33.
34.

Malignant variant of sclerosing perivascular epithelioid cell tumor arising in the adnexa.

Ramaiah S, Ganesan R, Mangham DC, McNally O, Klys HS, Hirschowitz L.

Int J Gynecol Pathol. 2009 Nov;28(6):589-93. doi: 10.1097/PGP.0b013e3181a3a4de.

PMID:
19851212
35.

Defining the sports medicine specialist in the United Kingdom: a Delphi study.

Thompson B, MacAuley D, McNally O, O'Neill S.

Br J Sports Med. 2004 Apr;38(2):214-7.

36.

The impact of the introduction of a fast track clinic on ovarian cancer referral patterns.

McNally OM, Wareham V, Flemming DJ, Cruickshank ME, Parkin DE.

Eur J Cancer Care (Engl). 2003 Dec;12(4):327-30.

PMID:
14982311
37.

How important is sport and exercise medicine to the accident and emergency specialist? A study in the UK and Ireland.

Abernethy L, MacAuley D, McNally O, McCann S.

Emerg Med J. 2003 Nov;20(6):540-2. No abstract available.

38.

Is optimal first-line chemotherapy deliverable in all newly diagnosed ovarian cancers? A population-based study.

McNally OM, Delaney E, Petty RD, Cruickshank ME, Hutcheon AW, Parkin DE.

Br J Cancer. 2003 Sep 15;89(6):966-7.

39.

Immediate care of school sport injury.

Abernethy L, MacAuley D, McNally O, McCann S.

Inj Prev. 2003 Sep;9(3):270-3.

40.

Life expectancies in the United Kingdom and Japan.

Nakaji S, MacAuley D, O'Neill S, McNally O, Baxter D, Sugawara K.

J Public Health Med. 2003 Jun;25(2):120-4.

PMID:
12848400
41.

VIN 3: a clinicopathologic review.

McNally OM, Mulvany NJ, Pagano R, Quinn MA, Rome RM.

Int J Gynecol Cancer. 2002 Sep-Oct;12(5):490-5.

PMID:
12366668
42.

Bone metastasis from epithelial ovarian carcinoma.

Petty RD, Gilbert F, Hutcheon AW, Sarkar TK, McNally O, Parkin D.

Lancet Oncol. 2002 Aug;3(8):513. No abstract available.

PMID:
12147438
43.

Successful treatment of mother and baby with metastatic choriocarcinoma.

McNally OM, Tran M, Fortune D, Quinn MA.

Int J Gynecol Cancer. 2002 Jul-Aug;12(4):394-8.

PMID:
12144689
44.

Sports medicine and the accident and emergency medicine specialist.

Abernethy L, McNally O, MacAuley D, O'Neill S.

Emerg Med J. 2002 May;19(3):239-41.

45.

Sterilization and disinfection in general practice within university health services.

McNally O, Thompson IM, McIlvenny G, Smyth ET, McBride N, MacAuley D.

J Hosp Infect. 2001 Nov;49(3):210-4.

PMID:
11716639
46.

First reported case of endometrial carcinoma in association with HIV infection.

Gard GB, McNally OM, Mulvany NJ, Bernshaw DM, Narayan K, Torresi J, Stewart JM, Quinn MA.

Int J Gynecol Cancer. 1999 May;9(3):259-263.

PMID:
11240777
47.

Sport and exercise medicine in undergraduate medical schools in the United Kingdom and Ireland.

Cullen M, McNally O, Neill SO, Macauley D.

Br J Sports Med. 2000 Aug;34(4):244-5. No abstract available.

48.

What is a sports medicine specialist? A pilot study.

Thompson B, McNally O, Neill SO, Macauley D.

Br J Sports Med. 2000 Aug;34(4):243-4. No abstract available.

49.

Induction of labour after 1 previous Caesarean section.

McNally OM, Turner MJ.

Aust N Z J Obstet Gynaecol. 1999 Nov;39(4):425-9.

PMID:
10687757
50.

Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region.

Poltorak A, Smirnova I, He X, Liu MY, Van Huffel C, McNally O, Birdwell D, Alejos E, Silva M, Du X, Thompson P, Chan EK, Ledesma J, Roe B, Clifton S, Vogel SN, Beutler B.

Blood Cells Mol Dis. 1998 Sep;24(3):340-55. Erratum in: Blood Cells Mol Dis 1999 Feb;25(1):78.

PMID:
10087992

Supplemental Content

Loading ...
Support Center